Genome&Co

formerly Genome & Company

Genome&Co is a biotech company in Suwon, South Korea, founded in 2015. It has raised $21.0M across 2 rounds, most recently a $21.0M Series B in March 2026.

지놈앤컴퍼니 Genome & Company

Headquarters
Suwon
Employees
51–200
Founded
2015
Business Model
B2B2C
Total Funding
$21.0M
Last Round
$21.0M Series BMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Genome & Company is a South Korean biopharmaceutical company developing immuno-oncology therapeutics, antibody-drug conjugates, medical-grade probiotics, and microbiome consumer products. It uses the GNOCLE genomics platform to discover new therapeutic targets and commercializes skin-health products through its UIQ microbiome cosmetics line from headquarters in Suwon, Gyeonggi-do.

Summary

It lists 51–200 employees. It has raised $21.0M in total across 2 rounds, most recently a $21.0M Series B round in Mar 2026. Investors include Pearl Abyss Capital and KB Investment.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BMar 2026
$21.0M

Sign up to see all 2 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genome&Co on Indexed.vc
<a href="https://indexed.vc/companies/genome-co"><img src="https://indexed.vc/api/badge/company/genome-co" alt="Genome&Co on Indexed.vc" width="260" height="76" /></a>